Manufacturing, Cell-Line Selection

The Search for Next-Gen Expression Systems

July 02, 2018

Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.

Sanofi Buys Berkeley Lights’ Cell Line Platform

April 20, 2018

The new platform is expected to speed up cell line development.

ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program

March 08, 2018

Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.

Novo Nordisk Publishes New Study on Bioproduction of Chemicals

February 20, 2018

The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.

Gilead Sciences and Kite to Acquire Cell Design Labs

December 08, 2017

Gilead Sciences will acquire Cell Design Labs to further cell-therapy research and development efforts.

Catalent and Grid Therapeutics Form Immuno-Oncology Pact

November 02, 2017

The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.

Batavia Biosciences Expands Viral Vector Facilities

October 16, 2017

The company announced plans to expand its viral vector process development facilities in the United States and its cleanroom facilities in the Netherlands for vector-based products.

Promethera and Shibuya Partner on New Cell-Therapy Manufacturing Platform

October 12, 2017

The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.

ProBioGen and Chiome in Antibody Manufacturing Deal

October 06, 2017

Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.

Horizon Discovery Releases CHO Genome Sequence for Bioproduction

August 01, 2017

Horizon to make publicly available its complete annotated CHO cell-line sequence in hopes of driving bioproduction cell-line innovation.